Evaluating the Efficacy of Ragweed-SPIRE Following Exposure to Ragweed Allergen in an Environmental Exposure Chamber

NCT02061709 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
280
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Circassia Limited

Collaborators